Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare Inc. has demonstrated significant financial performance, with its Marketplace utilization advancing to unprecedented levels and achieving a Medical Loss Ratio (MLR) of 95.6% in the third quarter of 2025, reflecting a quarter-over-quarter growth of 10.2%. Furthermore, the company experienced a substantial 360 basis point increase in Medicare margins to 93.6% in the same period, with guidance indicating an optimistic trend to 15% from the previous 11%. The ongoing expansion in Medicaid contracts and improvements in Marketplace metrics suggest favorable conditions for sustained growth and profitability in Molina Healthcare's operations moving forward.

Molina Healthcare's recent financial performance indicates significant challenges, with a 4Q25 EPS of ($2.75), which fell $3 short of expectations, largely due to pressures in its Medicaid segment. The company is anticipating margin compression in Medicaid, projecting a decrease to 1.2% in 2026, in contrast to higher margins maintained by competitors, which could lead to a projected 2.6% decline in Medicaid membership year-over-year. Additionally, revised estimates for adjusted EPS have been lowered for 2026 and 2027 to $5.04 and $7.66, reflecting adverse trends in both the Medicaid and Marketplace segments.